Skip to main content
Log in

Comparative Characteristics of Lipemia Models Induced by Injections of Triton WR-1339 and Poloxamer 407 in Mice

  • Methods
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Lipemia modeled by injections of Triton WR-1339 (500 mg/kg) and poloxamer 407 (500 mg/kg) to mice were compared. LP fraction and subfraction compositions were compared by small-angle X-ray scattering on a diffractometer. Both compounds in the same dose caused a sharp increase in serum concentrations of total cholesterol (CH) and triglycerides (TG), the increases in response to poloxamer 407 being more pronounced. The differences in the models consisted in the levels of atherogenic fractions: CH-VLDL (subfractions CH-VLDL1-2) and CH-LDL, which were higher under the effect of poloxamer 407. Similar increases were observed for atherogenic fractions: TG-VLDL (subfractions TG-VLDL1-2) and TG-LDL (subfractions TG-LDL1-3). A specifi c feature of the model induced by poloxamer 407 was elevation of the concentrations of antiatherogenic CH-HDL and TG-HDL (subfractions CH-HDL2 and TG-HDL2). Both models exhibited high similarity, but changes in atherogenic fractions were more pronounced under the effect of poloxamer 407.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. T. A. Korolenko, F. V. Tuzikov, E. D. Vasilyeva, et al., Bull. Exp. Biol. Med., 149, No. 5, 567-570 (2010).

    Article  PubMed  CAS  Google Scholar 

  2. V. M. Loginova, F. V. Tuzikov, N. A. Tuzikova, et al., Byull. Sib. Otdel. Rossiisk. Akad. Med. Nauk, 31, No. 2, 133-137 (2011).

    Google Scholar 

  3. Yu. I. Ragino, A. M. Chernyavskii, A. M. Volkov, and M. I. Voevoda, Atherosclerotic Plaque Instability Factors and Mechanisms [in Russian], Novosibirsk (2008).

  4. G. Dumortier, J. L. Grossiord, F. Agnely, and J. C. Chaumeil, Pharm. Res., 23, No. 12, 2709-2728 (2006).

    Article  PubMed  CAS  Google Scholar 

  5. T. P. Johnston and W. K. Palmer, Biochem. Pharmacol., 46, No. 6, 1037-1042 (1993).

    Article  PubMed  CAS  Google Scholar 

  6. T. P. Johnston and D. J. Waxman, J. Pharm. Pharmacol., 60, No. 6, 753-759 (2008).

    Article  PubMed  CAS  Google Scholar 

  7. T. A. Korolenko, F. V. Tuzikov, N. A. Tuzikova, et al., Health, 2, No. 7, 391-399 (2010).

    Article  Google Scholar 

  8. D. Kuzman, K. Fon Tacer, M. Cerne, et al., Acta Chim. Slov., 56, 262-269 (2009).

    CAS  Google Scholar 

  9. C. Leon, K. Wasan, K. Sachs-Barrable, and T. Johnston, Pharm. Res., 23, No. 7, 1597-1607 (2006).

    Article  PubMed  CAS  Google Scholar 

  10. J. S. Millar, D. A. Cromley, M. G. McCoy, et al., J. Lipid Res., 46, No. 9, 2023-2028 (2005).

    Article  PubMed  CAS  Google Scholar 

  11. S. Mora, J. D. Otvos, N. Rifai, et al., Circulation, 119, No. 17, 931-939 (2009).

    Article  PubMed  CAS  Google Scholar 

  12. J. D. Otvos, Clin. Lab., 48, Nos. 3-4, 171-180 (2002).

    PubMed  CAS  Google Scholar 

  13. P. Schneider, T. A. Korolenko, and U. Busch, Microsc. Res. Tech., 36, No. 4, 253-275 (1997).

    Article  PubMed  CAS  Google Scholar 

  14. F. V. Tuzikov, N. A. Tuzikova, R. V. Galimov, et al., Med. Sci. Monit., 8, No. 6, MT 79-88 (2002).

  15. T. Yasuda, T. Hirata, T. Ishida, et al., J. Atheroscler. Thromb., 14, No. 4, 192-201 (2007).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. A. Korolenko.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 155, No. 2, pp. 255-258, February, 2013

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loginova, V.M., Tuzikov, F.V., Tuzikova, N.A. et al. Comparative Characteristics of Lipemia Models Induced by Injections of Triton WR-1339 and Poloxamer 407 in Mice. Bull Exp Biol Med 155, 284–287 (2013). https://doi.org/10.1007/s10517-013-2133-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-013-2133-1

Key Words

Navigation